UCLA Presents voteview.com beta 3
112th Congress > House > Vote 1566
Clerk session vote number: 623
Sponsor: BURGESS, Michael C. (R-TX)
Description: Asthma Inhalers Relief Act
Bill summary: (This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Asthma Inhalers Relief Act of 2012 - Directs the Administrator of the Environmental Protection Agency (EPA) to: (1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act; (2) not take any enforcement action or otherwise seek to restrict the
distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and (3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.
Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012.
Terminates this Act on August 1, 2013.
Bill titles: To direct the Administrator of the Environmental Protection Agency to allow for the distribution, sale, and consumption in the United States of remaining inventories of over-the-counter CFC epinephrine inhalers.
Links for more info on the vote: congress.gov
